Last Price
0.031
Today's Change
+0.002 (6.89%)
Day's Change
0.029 - 0.031
Trading Volume
7,752,189
Market Cap
18 Million
Shares Outstanding
611 Million
Avg Volume
1,612,859
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.03
PE Ratio
-1.03
EPS
-0.03
Earnings Announcement
27-Jul-2025
Previous Close
0.03
Open
0.03
Day's Range
0.029 - 0.031
Year Range
0.021 - 0.05
Trading Volume
7,752,189
1 Day Change
6.90%
5 Day Change
14.81%
1 Month Change
24.00%
3 Month Change
0.00%
6 Month Change
-6.06%
Ytd Change
-13.89%
1 Year Change
-36.73%
3 Year Change
-84.72%
5 Year Change
-40.57%
10 Year Change
-77.87%
Max Change
-77.87%
No result.
Sector: Healthcare - Healthcare
Industry: Health Information Services
Description:
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.